An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache

Expert Review of Neurotherapeutics · Published 2026-06-28 · DOI 10.1080/14737175.2026.2688942

Free full text

Authors (5)

Amy Gimson, Nasia Christou, Fiona Greenwood, Stefania Maniataki, Peter J. Goadsby

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gimson, A., Christou, N., Greenwood, F., et al. (2026). An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2026.2688942

Related articles

• Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal? · Expert Review of Neurotherapeutics · 2025 · Same journal
• A conceptual framework based on current and emerging treatments for treatment-resistant depression: mechanistic evolution, clinical evidence, and future directions · Expert Review of Neurotherapeutics · 2026 · Same journal
• Optimizing cognitive behavioral therapy to treat anxiety among youth with autism spectrum disorders · Expert Review of Neurotherapeutics · 2025 · Same journal
• An update on the comorbidity of attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) and its clinical management · Expert Review of Neurotherapeutics · 2025 · Same journal
• Building a new arsenal: repurposed drugs and metronomic chemotherapy against medulloblastoma · Expert Review of Neurotherapeutics · 2026 · Same journal
• Contemporary and evolving perspectives on surgical therapies for essential tremor: deep brain stimulation and focused ultrasound · Expert Review of Neurotherapeutics · 2026 · Same journal
• The latest views on how vagus nerve stimulation works in epilepsy: a plain language summary · Expert Review of Neurotherapeutics · 2025 · Same journal
• Advances in targeted closed loop spinal cord stimulation to treat pain of the trunk and limbs · Expert Review of Neurotherapeutics · 2026 · Same journal
• Speech and language outcome measures in clinical trials of Alzheimer’s and Parkinson’s diseases · Expert Review of Neurotherapeutics · 2025 · Same journal
• The path to clinical application of human microglia transplantation for the treatment of CSF1R-related disorder · Expert Review of Neurotherapeutics · 2026 · Same journal